LCH-7749944

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

LCH-7749944 effectively suppresses the proliferation of human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and induces apoptosis.?

LCH-7749944 effectively suppresses the proliferation of human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and induces apoptosis.?LCH-7749944 is a potent PAK4 inhibitor with an IC50 of 14.93 μM.?LCH-7749944 (5-20 μM; 12-48 hours) prominently induces a dose-dependent increase in the percentage of cells in G1 phase and decrease in S phase. ?LCH-7749944 (5-30 μM; 24 hours) dramatically decreases levels of phosphoPAK4, phospho-c-Src, phospho-EGFR and cyclin D1 protein expression in a dose-dependent manner.?LCH-7749944 (GNF-PF-2356;?5-50 μM;?24 hours) inhibits the proliferation of MKN-1, BGC823, SGC7901 and MGC803 cells in a concentration dependent manner.??LCH-7749944 (5-20 μM;?12-48 hours) induces apoptosis of SGC7901 cells.??

GNF-PF-2356

Apoptosis

Apoptosis

PAK4;apoptosis

——

——

796888-12-5

350.41

C20H22N4O2

>98% (HPLC)

DMSO:250 mg/mL (713.45 mM; Need ultrasonic)

COc1cccc(Nc2nc(NCC3CCCO3)c3ccccc3n2)c1

——

(-20℃)

With Ice Pack

≥ 2 years